Abstract
Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have